Table 3.
Significantly enriched pathways.
| Pathway | p Value | UniGene number |
|---|---|---|
| T1 vs. T4 | ||
| Focal adhesion | 0 | 76 |
| ECM–receptor interaction | 6.80E−13 | 46 |
| Cytokine–cytokine receptor interaction | 1.42E−09 | 52 |
| Cell adhesion molecules | 1.13E−07 | 33 |
| TGF-β signaling pathway | 0.000100699 | 21 |
| Vascular smooth muscle contraction | 0.000111614 | 27 |
| Amebiasis | 0.000368349 | 6 |
| Melanogenesis | 0.000937358 | 22 |
| Calcium signaling pathway | 0.003524408 | 33 |
| Adherens junction | 0.004793109 | 17 |
| MAPK signaling pathway | 0.005027368 | 43 |
| Regulation of actin cytoskeleton | 0.006272819 | 36 |
| Wnt signaling pathway | 0.006320051 | 27 |
| Gap junction | 0.0071262 | 18 |
| Steroid hormone biosynthesis | 0.009703041 | 9 |
| Arrhythmogenic right ventricular cardiomyopathy | 0.013001616 | 5 |
| VEGF signaling pathway | 0.01314305 | 15 |
| Gastric acid secretion | 0.013974998 | 2 |
| Intestinal immune network for IgA production | 0.024274613 | 8 |
| Phosphatidylinositol signaling system | 0.028484703 | 16 |
| T2 vs. T5 | ||
| PPAR signaling pathway | 0.007689374 | 4 |
| Focal adhesion | 0.016837656 | 7 |
| Progesterone-mediated oocyte maturation | 0.019698938 | 4 |
| Dorsoventral axis formation | 0.03060988 | 2 |
| Cardiac muscle contraction | 0.035262584 | 3 |
| Lipoic acid metabolism | 0.039079049 | 1 |
| Oocyte meiosis | 0.040688919 | 4 |
| Adipocytokine signaling pathway | 0.047671798 | 3 |
| Wnt signaling pathway | 0.848944256 | 1 |
| T3 vs. T6 | ||
| Steroid biosynthesis | 0.0003184 | 5 |
| Phagosome | 0.0042824 | 12 |
| NOD-like receptor signaling pathway | 0.005853671 | 6 |
| Terpenoid backbone biosynthesis | 0.017505751 | 3 |
| DNA replication | 0.031551297 | 4 |
| Glycosaminoglycan biosynthesis—chondroitin sulfate | 0.048837386 | 3 |
| Wnt signaling pathway | 0.441815127 | 6 |